Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 1179533
[patent_doc_number] => 06740503
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-25
[patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes'
[patent_app_type] => B1
[patent_app_number] => 09/484317
[patent_app_country] => US
[patent_app_date] => 2000-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 62558
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/740/06740503.pdf
[firstpage_image] =>[orig_patent_app_number] => 09484317
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/484317 | Compositions and methods for non-targeted activation of endogenous genes | Jan 17, 2000 | Issued |
Array
(
[id] => 1410556
[patent_doc_number] => 06524824
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes'
[patent_app_type] => B1
[patent_app_number] => 09/481355
[patent_app_country] => US
[patent_app_date] => 2000-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 101
[patent_no_of_words] => 62555
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/524/06524824.pdf
[firstpage_image] =>[orig_patent_app_number] => 09481355
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/481355 | Compositions and methods for non-targeted activation of endogenous genes | Jan 11, 2000 | Issued |
Array
(
[id] => 1391592
[patent_doc_number] => 06541221
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes'
[patent_app_type] => B1
[patent_app_number] => 09/481282
[patent_app_country] => US
[patent_app_date] => 2000-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 101
[patent_no_of_words] => 62521
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/541/06541221.pdf
[firstpage_image] =>[orig_patent_app_number] => 09481282
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/481282 | Compositions and methods for non-targeted activation of endogenous genes | Jan 10, 2000 | Issued |
Array
(
[id] => 1125536
[patent_doc_number] => 06790442
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-14
[patent_title] => 'Genomic DNA encoding a polypeptide capable of inducing the production of interferon- '
[patent_app_type] => B1
[patent_app_number] => 09/479862
[patent_app_country] => US
[patent_app_date] => 2000-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17338
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/790/06790442.pdf
[firstpage_image] =>[orig_patent_app_number] => 09479862
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/479862 | Genomic DNA encoding a polypeptide capable of inducing the production of interferon- | Jan 9, 2000 | Issued |
Array
(
[id] => 4288191
[patent_doc_number] => 06268350
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Polynucleotides for inhibiting metastasis and tumor cell growth'
[patent_app_type] => 1
[patent_app_number] => 9/479524
[patent_app_country] => US
[patent_app_date] => 2000-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 11649
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268350.pdf
[firstpage_image] =>[orig_patent_app_number] => 479524
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/479524 | Polynucleotides for inhibiting metastasis and tumor cell growth | Jan 6, 2000 | Issued |
Array
(
[id] => 1253192
[patent_doc_number] => 06670185
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes'
[patent_app_type] => B1
[patent_app_number] => 09/479123
[patent_app_country] => US
[patent_app_date] => 2000-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 101
[patent_no_of_words] => 61415
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670185.pdf
[firstpage_image] =>[orig_patent_app_number] => 09479123
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/479123 | Compositions and methods for non-targeted activation of endogenous genes | Jan 6, 2000 | Issued |
Array
(
[id] => 4316090
[patent_doc_number] => 06316690
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Non-mammalian transgenic animal model for cellular proliferative diseases'
[patent_app_type] => 1
[patent_app_number] => 9/472661
[patent_app_country] => US
[patent_app_date] => 1999-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6917
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316690.pdf
[firstpage_image] =>[orig_patent_app_number] => 472661
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/472661 | Non-mammalian transgenic animal model for cellular proliferative diseases | Dec 26, 1999 | Issued |
Array
(
[id] => 968438
[patent_doc_number] => 06939712
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-09-06
[patent_title] => 'Muting gene activity using a transgenic nucleic acid'
[patent_app_type] => utility
[patent_app_number] => 09/472558
[patent_app_country] => US
[patent_app_date] => 1999-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 12996
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/939/06939712.pdf
[firstpage_image] =>[orig_patent_app_number] => 09472558
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/472558 | Muting gene activity using a transgenic nucleic acid | Dec 26, 1999 | Issued |
Array
(
[id] => 6080769
[patent_doc_number] => 20020081706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'NEGATIVE STRAND RNA VIRAL VECTOR HAVING AUTONOMOUS REPLICATION CAPABILITY'
[patent_app_type] => new
[patent_app_number] => 09/471840
[patent_app_country] => US
[patent_app_date] => 1999-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10052
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20020081706.pdf
[firstpage_image] =>[orig_patent_app_number] => 09471840
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/471840 | Negative strand RNA viral vector having autonomous replication capability | Dec 22, 1999 | Issued |
Array
(
[id] => 1043914
[patent_doc_number] => 06867348
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-15
[patent_title] => 'Methods and compositions for screening for angiogenesis modulating compounds'
[patent_app_type] => utility
[patent_app_number] => 09/465978
[patent_app_country] => US
[patent_app_date] => 1999-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 27091
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/867/06867348.pdf
[firstpage_image] =>[orig_patent_app_number] => 09465978
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/465978 | Methods and compositions for screening for angiogenesis modulating compounds | Dec 15, 1999 | Issued |
Array
(
[id] => 1323500
[patent_doc_number] => 06602686
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-05
[patent_title] => 'Compositions and method for non-targeted activation of endogenous genes'
[patent_app_type] => B1
[patent_app_number] => 09/455659
[patent_app_country] => US
[patent_app_date] => 1999-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 101
[patent_no_of_words] => 62532
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/602/06602686.pdf
[firstpage_image] =>[orig_patent_app_number] => 09455659
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/455659 | Compositions and method for non-targeted activation of endogenous genes | Dec 6, 1999 | Issued |
09/454925 | Methods and compositions useful for targeting activated vitronectin receptor alpha beta 3 | Dec 2, 1999 | Abandoned |
Array
(
[id] => 1516277
[patent_doc_number] => 06500422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-31
[patent_title] => 'Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (LAG-3)'
[patent_app_type] => B2
[patent_app_number] => 09/319147
[patent_app_country] => US
[patent_app_date] => 1999-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 6110
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/500/06500422.pdf
[firstpage_image] =>[orig_patent_app_number] => 09319147
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/319147 | Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (LAG-3) | Nov 30, 1999 | Issued |
Array
(
[id] => 1366007
[patent_doc_number] => 06566128
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Adenovirus vectors generated from helper viruses and helper-dependent vectors'
[patent_app_type] => B1
[patent_app_number] => 09/440809
[patent_app_country] => US
[patent_app_date] => 1999-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 9362
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566128.pdf
[firstpage_image] =>[orig_patent_app_number] => 09440809
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/440809 | Adenovirus vectors generated from helper viruses and helper-dependent vectors | Nov 14, 1999 | Issued |
Array
(
[id] => 1335166
[patent_doc_number] => 06593105
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-15
[patent_title] => 'Prion propagation inhibition by dominant-negative prion protein mutants'
[patent_app_type] => B1
[patent_app_number] => 09/367572
[patent_app_country] => US
[patent_app_date] => 1999-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 4212
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/593/06593105.pdf
[firstpage_image] =>[orig_patent_app_number] => 09367572
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/367572 | Prion propagation inhibition by dominant-negative prion protein mutants | Nov 2, 1999 | Issued |
Array
(
[id] => 7645388
[patent_doc_number] => 06472583
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-29
[patent_title] => 'Plasmid-based mutation detection system in transgenic fish'
[patent_app_type] => B1
[patent_app_number] => 09/427218
[patent_app_country] => US
[patent_app_date] => 1999-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12344
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/472/06472583.pdf
[firstpage_image] =>[orig_patent_app_number] => 09427218
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/427218 | Plasmid-based mutation detection system in transgenic fish | Oct 25, 1999 | Issued |
09/425406 | NOVEL G-PROTEIN COUPLED 7TM RECEPTOR (AXOR15) | Oct 21, 1999 | Abandoned |
09/403402 | NOVEL HUMAN TUMOUR SUPPRESSOR GENE | Oct 20, 1999 | Abandoned |
Array
(
[id] => 4255521
[patent_doc_number] => 06207878
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-27
[patent_title] => 'Sarcospan-deficient mouse as a model for clinical disorders associated with sarcospan mutations'
[patent_app_type] => 1
[patent_app_number] => 9/422762
[patent_app_country] => US
[patent_app_date] => 1999-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10262
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/207/06207878.pdf
[firstpage_image] =>[orig_patent_app_number] => 422762
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/422762 | Sarcospan-deficient mouse as a model for clinical disorders associated with sarcospan mutations | Oct 20, 1999 | Issued |
09/419379 | METHODS OF IDENTIFYING AGENTS THAT REGULATE PHOSPHORYLATION/DEPHOSPHORYLATION IN DOPAMINE SIGNALING | Oct 14, 1999 | Abandoned |